Safety and efficacy of botulinum toxin A in patients with trigeminal neuralgia: a double-blind, randomized, placebo-controlled, parallel-group trial and investigation of neuro-inflammatory biomarkers as predictors of efficacy
RecruitingCTIS2023-504567-17-00
Rigshospitalet, RigshospitaletTrigeminal neuralgia
Start: 2023-11-15Target: 80Updated: 2025-08-14